Drug-induced interstitial lung disease in the treatment of malignant lymphoma as a potential diagnostic marker: a comparison of serum Krebs von Lungen-6 and thymus and activation-regulated chemokine/CC chemokine ligand 17

PURPOSE: Cure-oriented treatment of malignant lymphoma (ML) is possible even in an advanced stage; however, the progression of drug-induced interstitial lung disease (DILD) sometimes accounts for poor clinical outcomes. This study aims to assess the incidence and clinical characteristics of DILD amo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamane, Hiromichi, Ochi, Nobuaki, Nagasaki, Yasunari, Yamagishi, Tomoko, Honda, Yoshihiro, Nakagawa, Nozomu, Takeyama, Masami, Nakanishi, Hidekazu, Takigawa, Nagio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110302/
https://www.ncbi.nlm.nih.gov/pubmed/30174428
http://dx.doi.org/10.2147/TCRM.S169824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110302/
https://www.ncbi.nlm.nih.gov/pubmed/30174428
http://dx.doi.org/10.2147/TCRM.S169824

Ejemplares similares